Related Experiment Video
Updated: Jun 22, 2026

Assessing Murine Resistance Artery Function Using Pressure Myography
Published on: June 7, 2013
Genetic basis of hypertension for the development of tailored medicine
Tomohiro Katsuya1, Ryuichi Morishita, Hiromi Rakugi
1Department of Clinical Gene Therapy, Osaka University Graduate School of Medicine, Suita, Japan. tkatsuya@iris.eonet.ne.jp
Abstract:
Similar to a tsunami wave, a new surge of genome-wide association studies in common complex diseases has succeeded in identifying the causative genetic risk factors of hypertension. The current status of genomic studies in hypertension, however, remains disorganized, and there are no clear solutions in sight. One possible reason for this disorganization is the small effect of each genetic variant on the predisposition to hypertension. Another reason could be that the morbidity of hypertension is typically used as a target to assess genetic contribution, which could be resolved by introducing new technology into the classical genetic analysis. In this review, we reaffirm the genetic basis of hypertension and outline recent progress in genomics. In addition, we discuss both the possibility and usefulness of genomic information in the development of tailored medicine.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Pharmacogenomics: Identification of New Drug Targets
Hypertension I: Introduction
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Hypertension II: Pathophysiology
